1525664900
Morgans Under the Microscope

Advertise on podcast: Morgans Under the Microscope

This podcast has
96 episodes
Language
English
Explicit
No
Date created
2020/07/30
Latest episode
2021/09/21
Average duration
11 min.
Release period
23 days

Description

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.

Unlock Morgans Under the Microscope podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Morgans Under the Microscope podcast


Under the microscope: Instascripts, Dr Asher Freilich CEO and Founder
2021/09/21
Dr Asher Freilich, CEO and founder of the online scripts business InstantScripts explains how concept evolved into a rapidly growing operation with big plans for the future.
Under the microscope: Audeara (ASX:AUA) Dr James Fielding, CEO
2021/08/05
Dr James Fielding founder and CEO of Audeara provides an update on the company’s progress. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #Healthcare
Under the microscope: Control Bionics (ASX:CBL) Rob Wong, CEO
2021/08/05
Rob Wong CEO of Control Bionics provides an update on the company’s progress. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #Healthcare
Under the microscope: Healthcare update - 8 July 2021
2021/07/08
Scott Power, Senior Analyst at Morgans speaks to the Morgans network. He updates on stocks in the Healthcare sector such as: Nanosonics (NAN), Resmed (RMD), Mach 7 (M7T), Impedimed (IPD), Audeara (AUA), Antisense Therapeutics (ANP), Neuren Pharmaceuticals (NEU). Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU
Under the microscope: Volpara Health Technologies (ASX:VHT): Ralph Highnam, CEO
2021/06/25
Ralph Highnam CEO and founder of Volpara Health (VHT.ASX) explains the significance of the technology and how its successfully being deployed across many breast clinics.
Under the microscope: Micro-X (ASX:MX1) - Peter Rowland, Managing Director
2021/06/02
Peter Rowland MD of Micro-X explains the significance of the next generation X-ray technology for global health and security markets. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #X-ray #Security #Healthcare
Under the microscope: Audeara (ASX:AUA) - Dr James Fielding, Chief Executive Officer
2021/05/06
Morgans healthcare analyst Iain Wilkie talks to Dr James Fielding, CEO of new IPO entrant Audeara (ASX:AUA) on what the company does and where its products fit within the audiology space. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #Innovation #Healthcare
Under the microscope: Control Bionics - Rob Wong, CEO
2021/04/12
Rob Wong Chief Executive Officer of Control Bionics, speaks with Scott Power from the Morgans Healthcare team, providing an update on the significant progress the company is making. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #Innovation #Healthcare
Under the microscope: ResApp (ASX:RAP) – Tony Keating, CEO and MD
2021/03/25
Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU
Under the microscope: Sector Update – Dr. Derek Jellinek, Senior Analyst
2021/02/10
Morgans Senior Analysis, Dr. Derek Jellinek, provides an update on the healthcare universe, including key upcoming catalysts. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU #Healthcare #Stocks #ReportingSeason
Under the microscope: Swift Media (ASX:SW1) - Pippa Leary, Chief Executive Officer
2021/02/04
Morgans Healthcare Analyst Iain Wilkie talks to Pippa Leary, Chief Executive Officer of Swift Media (ASX:SW1) for a high-level overview of the business, catalysts, and its shift into the large aged care sector.
Under the microscope: Micro X - Peter Rowland, CEO
2021/01/19
Scott Power from the Morgans Healthcare team speaks with Peter Rowland, CEO from Micro-X (ASX: MX1) where he explains the technology, its application, and upcoming catalysts for 2021.

Podcast reviews

Read Morgans Under the Microscope podcast reviews


0 out of 5
0 reviews

Podcast sponsorship advertising

Start advertising on Morgans Under the Microscope relevant audience podcasts


What do you want to promote?